In order to determine the character of the GSK3β role in astrocytoma grades II–IV, we examined the promoter methylation of the GSK3β gene and level of expression of active (pY216) and inactive (pS9) form of GSK3β protein. This evidence concerns the gene GSK3B and astrocytoma (excluding glioblastoma).